InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by O'Byrne Jason, Chief Financial Officer. Officer active across 1 companies, notably Caribou Biosciences, Inc.. Cumulatively, 2 reports have been logged. The latest transaction was filed on 8 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€87,40824,336 shares@ €3.59170.041% mcap50.0% of flow
Common Stock
SEC:0001209191-22-007860:0·
€87,40824,336 shares@ €3.59170.041% mcap100.0% of flow
Common Stock
SEC:0001209191-22-007860·
2 of 2 declarations
About O'Byrne Jason
Jason O'Byrne is the Chief Financial Officer of Caribou Biosciences, Inc., a biotechnology company. He is responsible for financial management, strategic planning, and investor relations. His role is crucial in ensuring the financial stability and growth of the company.
